RA Capital Management Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
43

- Investments
-
502
- Portfolio
-
131
- Exits
-
249

RA Capital Management General Information
Company Description
Founded in 2004, RA Capital Management is a venture capital firm headquartered in Boston, Massachusetts. The firm invests in early-stage companies. The firm also employs a long/short and sector-oriented hedge fund strategy. The firm prefers to invest in healthcare and life science companies developing drugs, medical devices, services & research tools, and diagnostics sectors based in the United States and Europe. This firm is a Registered Investment Adviser (RIA).
Business Details
Website
www.racap.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- 200 Berkeley Street
- 18th Floor
- Boston, MA 02116
- United States
RA Capital Management Investments & Acquisitions (502)
Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
---|---|---|---|---|---|---|
SpyGlass Pharma | 02-Jun-2025 | Later Stage VC | Surgical Devices | Clinical Trials - General | ||
CellCentric | 19-May-2025 | Biotechnology | Clinical Trials - Phase 1 | |||
Stylus Medicine | 14-May-2025 | Biotechnology | Generating Revenue | |||
Jade Biosciences | 28-Apr-2025 | Biotechnology | Generating Revenue | |||
Imbria Pharmaceuticals | 10-Apr-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
Vaxess Technologies | 09-Apr-2025 | Drug Discovery | Generating Revenue | |||
Aclaris Therapeutics | 25-Mar-2025 | Drug Discovery | Generating Revenue/Not Profitable | |||
Surrozen | 24-Mar-2025 | Drug Discovery | Pre-Clinical Trials | |||
Curevo Vaccine | 06-Mar-2025 | Later Stage VC | Drug Discovery | Clinical Trials - General | ||
Vivace Therapeutics | 28-Feb-2025 | Later Stage VC | Drug Discovery | Clinical Trials - Phase 3 |
RA Capital Management Exits (249)
Company Name | Exit Date | Exit Type | Exit Size |
---|---|---|---|
Synthego | 06-May-2025 | Bankruptcy: Admin/Reorg | |
Cerebral Therapeutics | 04-Apr-2025 | ||
Edgewise Therapeutics | 02-Apr-2025 | ||
IDRx | 21-Feb-2025 | ||
Qvella | 14-Feb-2025 | ||
Sionna Therapeutics | 07-Feb-2025 | ||
Metsera | 31-Jan-2025 | ||
Ocelot Bio | 20-Dec-2024 | ||
NewAmsterdam Pharma Company | 13-Dec-2024 | Public Investment 2nd Offering | |
Aliada Therapeutics | 11-Dec-2024 | Merger/Acquisition |
RA Capital Management Investments by Industry, Year, and Region
RA Capital Management Co-Investors (661)
Name | With | Exits | Lead Partner | Series | Industry |
---|---|---|---|---|---|
Janus Henderson Investors | 30 |
![]() |
![]() |
||
Logos Capital |
![]() |
![]() |
|||
OrbiMed |
![]() |
![]() |
|||
BVF Partners |
![]() |
![]() |
|||
Surveyor Capital |
![]() |
![]() |
RA Capital Management FAQs
-
What is RA Capital Management?
Founded in 2004, RA Capital Management is a venture capital firm headquartered in Boston, Massachusetts.
-
When was RA Capital Management founded?
RA Capital Management was founded in 2004.
-
Where is RA Capital Management headquartered?
RA Capital Management is headquartered in Boston, MA.
-
What is RA Capital Management's total asset value?
RA Capital Management has around
in total assets under management. -
How many investments has RA Capital Management made?
RA Capital Management has made 502 investments.
-
What has RA Capital Management invested in?
RA Capital Management has made numerous investments in companies like SpyGlass Pharma, CellCentric, and Stylus Medicine within the Surgical Devices and Biotechnology industries.
-
What has RA Capital Management invested in recently?
RA Capital Management's latest investment was on 02-Jun-2025 in SpyGlass Pharma, a company within the Surgical Devices industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »